|
시장보고서
상품코드
2065258
불임 치료 시장 규모, 점유율, 성장 분석 : 치료 유형별, 제품 유형, 시술 유형별, 환자 유형별, 최종사용자별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)Fertility Market Size, Share, and Growth Analysis, By Treatment Type, By Product & Service Type, By Procedure Type, By Patient Type, By End User, By Distribution Channel, By Region - Industry Forecast 2026-2033 |
||||||
세계의 불임 치료 시장 규모는 2024년에 323억 달러로 평가되었으며, 2025년 351억 달러에서 2033년까지 683억 2,000만 달러로 확대되어 예측 기간(2026-2033년) 동안 CAGR 8.7%로 성장할 것으로 전망됩니다.
세계 불임 치료 시장은 출산 연령의 상승과 불임률 증가와 같은 인구 동향의 변화를 배경으로 눈부신 성장을 이루고 있습니다. 이 분야에는 보조생식기술, 진단, 의약품, 기증자 서비스 등이 포함되며, 이러한 요소들이 서로 어우러져 개인이나 부부의 임신 가능성을 높이고 있습니다. 착상 전 유전자 검사(PGT) 및 첨단 배아 동결 기술 등의 혁신으로 임상 성과가 향상되었고, 그 결과 성공률과 누적 비용 대비 효과가 높아짐에 따라 시장이 확대되고 있습니다. 또한, 기업의 불임 치료 지원 제도와 난자 동결 프로그램은 특히 도시 지역에서 경력을 중시하는 여성들의 관심을 끌고 있습니다. 또한, 불임 치료 관광도 증가 추세를 보이고 있으며, 합리적인 가격으로 첨단 불임 치료 솔루션을 제공하는 국가들로 사람들이 찾아가면서, 불임 관련 기술, 데이터 분석 및 맞춤형 치료 프로토콜 분야에서 국제적인 협력과 투자가 촉진되고 있습니다.
세계 불임 치료 시장의 성장요인
불임 유병률이 증가함에 따라 진단, 치료 및 지원성 불임 치료 서비스에 대한 수요가 높아지고 있으며, 지원을 요청하는 사람들의 수가 늘어나고 있습니다. 이러한 수요의 급증에 따라, 클리닉과 검사 기관들은 다양한 환자의 요구에 부응하기 위해 역량 강화와 치료 메뉴 확충에 힘쓰고 있습니다. 또한, 의료 제공자들은 성공률을 높이기 위해 첨단 기술과 전문 연수에 대한 투자를 우선시하고 있으며, 이는 궁극적으로 더 많은 환자를 유치하고 환자들이 더 조기에 의료 상담을 받도록 유도하고 있습니다. 이러한 지속적인 추세가 견조한 시장 수요를 창출하고 있으며, 다양한 지역에서 관련 제품, 치료 및 서비스의 지속적인 이용으로 이어지고 있습니다.
세계 불임 치료 시장의 제약요인
불임 치료에 따르는 고액의 비용은 많은 사람들에게 큰 장벽이 되어 치료 접근성을 제한하고, 시장 전체의 성장을 저해하고 있습니다. 환자가 본인 부담금이나 불충분한 보험 적용에 직면하게 되면, 이러한 서비스에 대한 경제적 부담이 커져 주로 부유층의 수요에 그치게 됩니다. 이러한 수요 집중은 불임 치료의 광범위한 이용을 방해하고, 그 보급을 지연시키는 결과를 초래합니다. 또한, 높은 비용은 적시 개입을 방해할 가능성이 있으며, 잠재적 환자들이 치료 계획을 연기하거나 포기하게 만드는 원인이 되어, 궁극적으로는 장기적인 서비스 제공 가능성에 영향을 미칩니다. 그 결과, 이러한 상황은 고객 기반을 축소시키고 각 지역에서의 꾸준한 성장을 저해함으로써 시장 확대를 제한하고 있습니다.
세계 불임 치료 시장의 동향
세계 불임 치료 시장에서는 디지털 기술과 원격의료의 통합이 점점 더 진전되면서, 생식 의료 서비스의 제공 형태를 크게 변화시키고 있습니다. 온라인 진료 및 원격 모니터링 기능을 통해 환자와의 지속적인 소통과 맞춤형 치료 경험이 가능해지는 한편, 외딴 지역에 거주하는 사람들의 의료 접근성도 향상되고 있습니다. 전자 진료 기록 및 상호 운용 가능한 데이터의 도입으로 의료 제공자 간의 원활한 협력이 촉진되어, 임상적 의사결정 및 후속 관리 과정이 효율화되고 있습니다. 이러한 변화는 진료소의 업무 흐름을 재정의할 뿐만 아니라, 환자 중심의 접근 방식에 부합하는 새로운 직원 역량 개발도 필요로 합니다. 결국, 이러한 혁신은 편의성, 투명성, 그리고 치료상의 신뢰 관계 구축을 중시하는 차별화된 서비스 제공의 길을 열어줄 것입니다.
자주 묻는 질문
목차
소개
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 불임 치료 시장 규모 : 치료 유형별
세계의 불임 치료 시장 규모 : 제품 및 서비스 유형별
세계의 불임 치료 시장 규모 : 시술 유형별
세계의 불임 치료 시장 규모 : 환자 유형별
세계의 불임 치료 시장 규모 : 최종사용자별
세계의 불임 치료 시장 규모 : 유통 채널별
세계의 불임 치료 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSMGlobal Fertility Market size was valued at USD 32.30 Billion in 2024 and is poised to grow from USD 35.10 Billion in 2025 to USD 68.32 Billion by 2033, growing at a CAGR of 8.7% during the forecast period (2026-2033).
The global fertility market is experiencing significant growth, driven by demographic changes such as delayed childbearing and rising infertility rates. This sector encompasses assisted reproductive technologies, diagnostics, pharmaceuticals, and donor services, which collectively enhance individuals' and couples' chances of conception. Innovations like pre-implantation genetic testing (PGT) and advanced embryo freezing techniques have improved clinical outcomes, consequently expanding the market as success rates and cumulative cost efficiencies rise. Additionally, corporate fertility benefits and egg freezing programs have attracted career-focused women, particularly in urban settings. Fertility tourism is also on the rise, with individuals traveling to countries offering affordable and advanced fertility solutions, fostering international collaboration and investment in fertility-related technologies, data analytics, and customized treatment protocols.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fertility market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Fertility Market Segments Analysis
Global fertility market is segmented by treatment type, product & service type, procedure type, patient type, end user, distribution channel and region. Based on treatment type, the market is segmented into assisted reproductive technology (ART), artificial insemination, fertility preservation and fertility drugs & hormonal therapy. Based on product & service type, the market is segmented into fertility drugs, fertility consumables & media, fertility equipment, fertility testing & diagnostics and fertility clinic services. Based on procedure type, the market is segmented into fresh non-donor cycles, frozen non-donor cycles, donor egg cycles, donor embryo cycles and gestational carrier cycles. Based on patient type, the market is segmented into female infertility, male infertility, combined infertility, unexplained infertility and single parents & LGBTQ+ families. Based on end user, the market is segmented into fertility clinics, hospitals, surgical centers, cryobanks & fertility preservation centers and research institutes. Based on distribution channel, the market is segmented into direct tender & institutional sales, retail pharmacies, specialty pharmacies and online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Fertility Market
The increasing prevalence of infertility has led to a greater demand for diagnostic, therapeutic, and supportive fertility services, resulting in a larger number of individuals seeking assistance. This surge in need encourages clinics and laboratories to enhance their capabilities and broaden their treatment offerings to cater to diverse patient needs. Furthermore, healthcare providers are prioritizing investments in advanced technology and specialized training to boost success rates, ultimately drawing in more patients and prompting them to seek medical advice sooner. This ongoing trend fosters robust market demand, leading to continuous utilization of related products, procedures, and services throughout various regions.
Restraints in the Global Fertility Market
The high expenses related to fertility treatments create significant barriers for many individuals, restricting access and limiting overall market growth. When patients face substantial out-of-pocket costs and inadequate insurance coverage, the affordability of these services diminishes, leading to demand primarily from wealthier demographics. This concentration of demand hampers widespread utilization and results in slower adoption of fertility treatments. Additionally, elevated costs may discourage timely intervention, prompting potential patients to delay or abandon their treatment plans, ultimately impacting long-term service availability. Consequently, this situation restricts market expansion by reducing the customer base and impeding consistent growth across various regions.
Market Trends of the Global Fertility Market
The global fertility market is increasingly embracing digital and telehealth integration, significantly transforming the delivery of reproductive healthcare services. Virtual consultations and remote monitoring capabilities are enabling continuous patient engagement and personalized treatment experiences, while enhancing access for individuals in remote areas. The incorporation of electronic health records and interoperable data fosters seamless coordination among healthcare providers, streamlining clinical decision-making and follow-up processes. This shift not only redefines clinic workflows but also necessitates the development of new staff competencies that align with a patient-centric approach. Ultimately, these innovations pave the way for differentiated offerings that emphasize convenience, transparency, and nurturing therapeutic relationships.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Fertility Market Size by Treatment Type & CAGR (2026-2033)
- Market Overview
- Assisted Reproductive Technology (ART)
- In Vitro Fertilization (IVF)
- Intracytoplasmic Sperm Injection (ICSI)
- Frozen Embryo Transfer (FET)
- Donor Egg & Donor Sperm Procedures
- Surrogacy Services
- Artificial Insemination
- Intrauterine Insemination (IUI)
- Intracervical Insemination (ICI)
- Fertility Preservation
- Egg Freezing
- Sperm Freezing
- Embryo Cryopreservation
- Fertility Drugs & Hormonal Therapy
- Ovulation Induction Drugs
- Gonadotropins
- Hormonal Support Therapy
Global Fertility Market Size by Product & Service Type & CAGR (2026-2033)
- Market Overview
- Fertility Drugs
- Fertility Consumables & Media
- Fertility Equipment
- Imaging Systems
- Incubators
- Micromanipulation Systems
- Cryopreservation Systems
- Fertility Testing & Diagnostics
- Fertility Clinic Services
Global Fertility Market Size by Procedure Type & CAGR (2026-2033)
- Market Overview
- Fresh Non-Donor Cycles
- Frozen Non-Donor Cycles
- Donor Egg Cycles
- Donor Embryo Cycles
- Gestational Carrier Cycles
Global Fertility Market Size by Patient Type & CAGR (2026-2033)
- Market Overview
- Female Infertility
- Male Infertility
- Combined Infertility
- Unexplained Infertility
- Single Parents & LGBTQ+ Families
Global Fertility Market Size by End User & CAGR (2026-2033)
- Market Overview
- Fertility Clinics
- Hospitals
- Surgical Centers
- Cryobanks & Fertility Preservation Centers
- Research Institutes
Global Fertility Market Size by Distribution Channel & CAGR (2026-2033)
- Market Overview
- Direct Tender & Institutional Sales
- Retail Pharmacies
- Specialty Pharmacies
- Online Pharmacies
Global Fertility Market Size & CAGR (2026-2033)
- North America (Treatment Type, Product & Service Type, Procedure Type, Patient Type, End User, Distribution Channel)
- US
- Canada
- Europe (Treatment Type, Product & Service Type, Procedure Type, Patient Type, End User, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Treatment Type, Product & Service Type, Procedure Type, Patient Type, End User, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Treatment Type, Product & Service Type, Procedure Type, Patient Type, End User, Distribution Channel)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Treatment Type, Product & Service Type, Procedure Type, Patient Type, End User, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- CooperSurgical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vitrolife Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- FUJIFILM Irvine Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hamilton Thorne
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cook Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Kitazato Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Esco Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Genea Biomedx
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Progyny
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- IVI RMA Global
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Virtus Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Monash IVF Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ferring Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Organon
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Gedeon Richter
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bloom IVF Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Apollo Fertility
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Gaudium IVF
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
